Quantitative two‐dimensional HRMAS 1H‐NMR spectroscopy‐based metabolite profiling of human cancer cell lines and response to chemotherapy
暂无分享,去创建一个
Daniel Morvan | Georges Stepien | D. Morvan | A. Demidem | D. Loiseau | Chantal Barthomeuf | M. Bayet-Robert | C. Barthomeuf | Mathilde Bayet-Robert | Dominique Loiseau | Pascale Rio | Aicha Demidem | P. Rio | G. Stepien
[1] Y. Mardor,et al. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. , 2001, Cancer research.
[2] M. Cascante,et al. The Stable Isotope-based Dynamic Metabolic Profile of Butyrate-induced HT29 Cell Differentiation* , 2003, Journal of Biological Chemistry.
[3] P. Kehrli,et al. Toward improved grading of malignancy in oligodendrogliomas using metabolomics , 2008, Magnetic resonance in medicine.
[4] Z. Bhujwalla,et al. Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.
[5] D. Morvan,et al. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy , 2009, Molecular carcinogenesis.
[6] O. Ohlenschläger,et al. NMR secondary structure of the plasminogen activator protein staphylokinase , 1997, Journal of biomolecular NMR.
[7] S. Canevari,et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. , 2005, Cancer research.
[8] S. Jackowski,et al. Cellular Responses to Excess Phospholipid* , 1999, The Journal of Biological Chemistry.
[9] David Gallego-Ortega,et al. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. , 2008, The international journal of biochemistry & cell biology.
[10] B. Halliwell,et al. Human skin keloid fibroblasts display bioenergetics of cancer cells. , 2008, The Journal of investigative dermatology.
[11] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[12] Daniel Raftery,et al. Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. , 2005, Analytical chemistry.
[13] M. Medina,et al. Glutamine, as a precursor of glutathione, and oxidative stress. , 1999, Molecular genetics and metabolism.
[14] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[15] Theodoros N. Arvanitis,et al. An algorithm for the automated quantitation of metabolites in in vitro NMR signals , 2006, Magnetic resonance in medicine.
[16] D. Morvan,et al. Methionine‐dependence phenotype of tumors: Metabolite profiling in a melanoma model using L‐[methyl‐13C]methionine and high‐resolution magic angle spinning 1H–13C nuclear magnetic resonance spectroscopy , 2006, Magnetic resonance in medicine.
[17] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[18] G. Yancey Gillespie,et al. Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines , 2005, Journal of Neuro-Oncology.
[19] Daniel Morvan,et al. Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses , 2010, Breast Cancer Research and Treatment.
[20] K. Willison,et al. Substantial CCT activity is required for cell cycle progression and cytoskeletal organization in mammalian cells. , 2006, Experimental cell research.
[21] Julian L. Griffin,et al. Metabolic profiles of cancer cells , 2004, Nature Reviews Cancer.
[22] Adam L. Meadows,et al. Metabolic and Morphological Differences between Rapidly Proliferating Cancerous and Normal Breast Epithelial Cells , 2008, Biotechnology progress.
[23] C. Mountford,et al. Tetraphenylphosphonium chloride induced mr‐visible lipid accumulation in a malignant human breast cell line , 1996, International journal of cancer.
[24] Gema Moreno-Bueno,et al. Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines , 2007, Cell cycle.
[25] C. Arús,et al. 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT‐29 cells in nude mice spleen , 1998, NMR in biomedicine.
[26] D. Cory,et al. Biochemical correlates of thiazolidinedione‐induced adipocyte differentiation by high‐resolution magic angle spinning NMR spectroscopy , 2002, Magnetic resonance in medicine.
[27] D. Morvan,et al. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. , 2007, Cancer research.
[28] D. Morvan,et al. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. , 2002, Cancer research.
[29] D. Wallace,et al. Mitochondria and cancer: Warburg addressed. , 2005, Cold Spring Harbor symposia on quantitative biology.
[30] W. Mackinnon,et al. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy , 1994, International journal of cancer.
[31] D. Morvan,et al. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: Demonstration of phospholipid metabolism alterations , 2003, Magnetic resonance in medicine.
[32] F. Howe,et al. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel , 2008, Magnetic resonance in medicine.
[33] V. Raman,et al. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. , 2005, Cancer research.
[34] C. Pannecouque,et al. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. , 2000, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[35] R. Pankov,et al. Ha‐ ras‐TRANSFORMATION ALTERS THE METABOLISM OF PHOSPHATIDYLETHANOLAMINE AND PHOSPHATIDYLCHOLINE IN NIH 3T3 FIBROBLASTS , 1999, Cell biology international.
[36] N. Michel,et al. The application of the ERETIC method to 2D-NMR. , 2004, Journal of magnetic resonance.